T 2409/13 (CDR-Repaired Antibodies/GENENTECH) of 06.09.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T240913.20180906
- Date of decision
- 6 September 2018
- Case number
- T 2409/13
- Petition for review of
- -
- Application number
- 05723312.4
- IPC class
- C07K 16/46
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CDR-Repaired Antibodies
- Applicant name
- Genentech, Inc.
- Opponent name
- Glaxo Group Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84
- Keywords
- Novelty - main and auxiliary requests 1 and 3 (no)
Inventive step - auxiliary requests 1 and 2 (no)
Amendments - auxiliary request 4
Amendments - added subject-matter (yes) - Catchword
- -
- Cited cases
- T 0681/01
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.